These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6428914)

  • 1. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H; Eisenburg J; Paumgartner G
    Eur J Clin Pharmacol; 1984; 26(4):449-51. PubMed ID: 6428914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM; Bartholomew TC; Jewell DP
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.
    Sircar JC; Schwender CF; Carethers ME
    Biochem Pharmacol; 1983 Jan; 32(1):170-2. PubMed ID: 6131674
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of sulphasalazine, sulphapyridine, 5-aminosalicylic acid and prednisolone on superoxide production by human polymorphonuclear leukocytes: in vitro studies].
    Ide T
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2090. PubMed ID: 3025481
    [No Abstract]   [Full Text] [Related]  

  • 5. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?
    Aruoma OI; Wasil M; Halliwell B; Hoey BM; Butler J
    Biochem Pharmacol; 1987 Nov; 36(21):3739-42. PubMed ID: 2890355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
    Gibson PR; Jewell DP
    Clin Sci (Lond); 1985 Aug; 69(2):177-84. PubMed ID: 2866061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ; Lo Casto M
    Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
    Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
    Reynolds PD; Middleton SJ; Shorthouse M; Hunter JO
    Aliment Pharmacol Ther; 1995 Oct; 9(5):491-5. PubMed ID: 8580268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites.
    Collier HO; Francis AA; McDonald-Gibson WJ; Saeed SA
    Prostaglandins; 1976 Feb; 11(2):219-25. PubMed ID: 4854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
    Hawkey CJ; Boughton-Smith NK; Whittle BJ
    Dig Dis Sci; 1985 Dec; 30(12):1161-5. PubMed ID: 2866075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR; Moore PK
    Br J Pharmacol; 1980 Apr; 68(4):719-30. PubMed ID: 6103724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
    Kolassa N; Becker R; Wiener H
    Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased suppressor cell activity in inflammatory bowel disease.
    Holdstock G; Chastenay BF; Krawitt EL
    Gut; 1981 Dec; 22(12):1025-30. PubMed ID: 6119275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones. Brief report.
    Andreasen JJ; Andersen LP; Hartzen SH
    APMIS; 1988 Jun; 96(6):568-70. PubMed ID: 2899438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Azad Khan AK; Piris J; Truelove SC
    Lancet; 1977 Oct; 2(8044):892-5. PubMed ID: 72239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.
    Greenfield SM; Punchard NA; Thompson RP
    Gut; 1991 Oct; 32(10):1156-9. PubMed ID: 1683330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.